Physician profile
John Michael George
NPI 1891798856
$36,447.36
in general payments reported to CMS, 2019-2025
28 companies · $1,672 in 2025
The $1,672 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $3,244 · 2021: $1,255 · 2022: $1,324 · 2023: $1,622 · 2024: $5,233 · 2025: $1,672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,567 · Travel and Lodging: $2,951 · Education: $9.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,567.09 |
| Travel and Lodging | $2,950.72 |
| Education | $9.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $20,187.43 | 2019-2025 | Andexxa, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4,810.60 | 2019-2025 | Lifevest |
| Medtronic, INC. | $3,819.72 | 2022-2025 | Symplicity G3, Corevalve Evolut R, Onyx Frontier |
| Abiomed | $1,503.04 | 2021-2025 | Impella |
| Biotronik INC. | $1,262.85 | 2019-2025 | Amvia Edge, Zero Gravity, Acticor 7 Vr-T Dx |
| Boston Scientific Corporation | $1,233.14 | 2019-2024 | Watchman Flx, Avvigo Guidance System, Lux-Dx Insertable Cardiac Monitor |
| Impulse Dynamics (USA) INC. | $713.17 | 2021-2023 | Optimizer |
| Abbott Laboratories | $535.09 | 2021-2025 | Xience Skypoint, Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx |
| Aop Health US, LLC | $532.90 | 2025 | Rapiblyk |
| Heartflow, INC. | $501.35 | 2020-2025 | |
| Amgen INC. | $270.86 | 2019-2025 | Repatha, Repatha |
| Kestra Medical Technology Services, INC. | $258.79 | 2025 | Assure Wcd |
| Shockwave Medical, INC | $154.70 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $121.82 | 2021-2025 | Azurion 5 M20 |
| Penumbra, INC. | $109.89 | 2023 | Indigo System |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $66.19 | 2019-2021 | |
| Angiodynamics, INC. | $62.70 | 2022-2024 | Angiovac |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.25 | 2025 | Jardiance |
| Vital Connect, INC | $48.64 | 2023 | Vitalpatch Rtm |
| Novartis Pharmaceuticals Corporation | $43.31 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.03 | 2025 | |
| Biosense Webster, INC. | $31.15 | 2025 | Carto 3 |
| Becton, Dickinson and Company | $22.88 | 2024 | Lutonix Drug Coated Balloon |
| E.R. Squibb & Sons, L.L.C. | $21.19 | 2025 | Eliquis |
| Allergan, INC. | $12.86 | 2019 | |
| Integra Lifesciences Corporation | $12.75 | 2021 | |
| Pfizer INC. | $11.06 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.